Fifty years of subclinical primary aldosteronism: Importance of early diagnosis

Clinical presentation of excessive aldosterone secretion is often not specific. The presence of resistant severe hypertension (HT) and signs of hypokalemia is useful but inconsistent characteristic. Plasma aldosterone level in primary aldosteronism (PA) could be normal, although inappropriately...

Full description

Bibliographic Details
Main Authors: Ćirić Jasmina, Žarković Miloš, Beleslin Biljana
Format: Article
Language:English
Published: Serbian Medical Society 2012-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2012/0370-81791212800C.pdf
_version_ 1818563297923825664
author Ćirić Jasmina
Žarković Miloš
Beleslin Biljana
author_facet Ćirić Jasmina
Žarković Miloš
Beleslin Biljana
author_sort Ćirić Jasmina
collection DOAJ
description Clinical presentation of excessive aldosterone secretion is often not specific. The presence of resistant severe hypertension (HT) and signs of hypokalemia is useful but inconsistent characteristic. Plasma aldosterone level in primary aldosteronism (PA) could be normal, although inappropriately high for a low plasma renin activity and not suppressed by sodium. Screening of hypertensive population with no obvious signs of PA has revealed an increased prevalence of idiopathic adrenal hyperplasia as a cause of aldosterone excess. Nowadays, PA is the most common endocrine form of secondary HT, with an estimated prevalence 5-10% of hypertensive population. The diagnosis of PA can lead to surgical cure in the case of aldosterone producing adenoma and unilateral adrenal hyperplasia. The aldosterone excess is responsible for vascular inflammation and end-organ damage. Left ventricular hypertrophy, cardiac arrhythmia and cerebral insult are frequently seen in PA and preventable by mineralocorticoid receptor blockers. For this reason, screening for PA in patients with HT and hypokalemia and/or adrenal incidentaloma, resistant and severe HT, and in patients with the onset of HT at young age is advisable. The most widely accepted screening for PA is serum aldosterone to plasma rennin activity (aldosterone : PRA) ratio, with the cut-off of 30 ng/dl:ng/ml/h. Serum aldosterone level could be included as an additional screening parameter. Confirmatory tests are crucial for the diagnosis of PA in patients with an increased aldosterone : PRA ratio and subtype differentiation for the choice of treatment. [Projekat Ministarstva nauke Republike Srbije, br. br. 175036 i br. 175067]
first_indexed 2024-12-14T01:14:50Z
format Article
id doaj.art-a2c396941ceb41a0ac9531117e2852a7
institution Directory Open Access Journal
issn 0370-8179
language English
last_indexed 2024-12-14T01:14:50Z
publishDate 2012-01-01
publisher Serbian Medical Society
record_format Article
series Srpski Arhiv za Celokupno Lekarstvo
spelling doaj.art-a2c396941ceb41a0ac9531117e2852a72022-12-21T23:22:38ZengSerbian Medical SocietySrpski Arhiv za Celokupno Lekarstvo0370-81792012-01-0114011-1280080510.2298/SARH1212800CFifty years of subclinical primary aldosteronism: Importance of early diagnosisĆirić JasminaŽarković MilošBeleslin BiljanaClinical presentation of excessive aldosterone secretion is often not specific. The presence of resistant severe hypertension (HT) and signs of hypokalemia is useful but inconsistent characteristic. Plasma aldosterone level in primary aldosteronism (PA) could be normal, although inappropriately high for a low plasma renin activity and not suppressed by sodium. Screening of hypertensive population with no obvious signs of PA has revealed an increased prevalence of idiopathic adrenal hyperplasia as a cause of aldosterone excess. Nowadays, PA is the most common endocrine form of secondary HT, with an estimated prevalence 5-10% of hypertensive population. The diagnosis of PA can lead to surgical cure in the case of aldosterone producing adenoma and unilateral adrenal hyperplasia. The aldosterone excess is responsible for vascular inflammation and end-organ damage. Left ventricular hypertrophy, cardiac arrhythmia and cerebral insult are frequently seen in PA and preventable by mineralocorticoid receptor blockers. For this reason, screening for PA in patients with HT and hypokalemia and/or adrenal incidentaloma, resistant and severe HT, and in patients with the onset of HT at young age is advisable. The most widely accepted screening for PA is serum aldosterone to plasma rennin activity (aldosterone : PRA) ratio, with the cut-off of 30 ng/dl:ng/ml/h. Serum aldosterone level could be included as an additional screening parameter. Confirmatory tests are crucial for the diagnosis of PA in patients with an increased aldosterone : PRA ratio and subtype differentiation for the choice of treatment. [Projekat Ministarstva nauke Republike Srbije, br. br. 175036 i br. 175067]http://www.doiserbia.nb.rs/img/doi/0370-8179/2012/0370-81791212800C.pdfprimary aldosteronismhypertensionscreening test
spellingShingle Ćirić Jasmina
Žarković Miloš
Beleslin Biljana
Fifty years of subclinical primary aldosteronism: Importance of early diagnosis
Srpski Arhiv za Celokupno Lekarstvo
primary aldosteronism
hypertension
screening test
title Fifty years of subclinical primary aldosteronism: Importance of early diagnosis
title_full Fifty years of subclinical primary aldosteronism: Importance of early diagnosis
title_fullStr Fifty years of subclinical primary aldosteronism: Importance of early diagnosis
title_full_unstemmed Fifty years of subclinical primary aldosteronism: Importance of early diagnosis
title_short Fifty years of subclinical primary aldosteronism: Importance of early diagnosis
title_sort fifty years of subclinical primary aldosteronism importance of early diagnosis
topic primary aldosteronism
hypertension
screening test
url http://www.doiserbia.nb.rs/img/doi/0370-8179/2012/0370-81791212800C.pdf
work_keys_str_mv AT ciricjasmina fiftyyearsofsubclinicalprimaryaldosteronismimportanceofearlydiagnosis
AT zarkovicmilos fiftyyearsofsubclinicalprimaryaldosteronismimportanceofearlydiagnosis
AT beleslinbiljana fiftyyearsofsubclinicalprimaryaldosteronismimportanceofearlydiagnosis